iFlash-SARS-CoV-2 IgM/IgG Antibody Test

It applies the chemiluminescent immunosassay (CLIA) for the qualitative detection of SARS-COV-2 antibody in nasal swab or nasopharyngeal swab.
Category
COVID-19
Product Overview

Features

  • Comprehensive solution: Reagent kits for both IgG and IgM tests for SARS-CoV-2 can provide comprehensive solution for the detection of COVID-19.
  • Patented design: With strong social responsibility and professional R&D team, we made independent development of raw materials and stable supply for new assays within 1 month
  • High specificity: Anti-interference to Legionella pneumococcal, mycoplasma pneumonia, chlamydia pneumonia, adenoviruses, respiratory syncytial viruses, influenza A, influenza B and para-flu viruses 1, 2 and 3, etc.
  • Speed: Up to 1200 T/H can be achieved by our iFlash series CLIA analyzers (iFLash 1800: 180 T/H; iFlash 3000: 300 T/H, iModule: up to 1200 T/H).
Language
Search
亚辉龙

Join Us

关注我们

Wechat

Headquarter: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China

Follow YHLO

wechatwechat wechat wechat wechat

© 2020  Shenzhen YHLO Biotech Co., Ltd.  All rights reserved.  粤ICP备19040167号